AAT vs ALEX

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score data, which raises transparency risks. Despite a high dividend yield of 7.51%, the payout ratio of 132.84% is unsustainable, supported by collapsing earnings—YoY EPS down 75% and revenue down 10.8%. Valuation metrics are mixed, with a Price/Book below 1 but a high Forward P/E of 24.97, while technical and analyst signals are uniformly bearish. The company has underperformed peers over 1Y, 3Y, and 5Y, with no insider buying and weak earnings consistency in recent quarters.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite strong historical price performance and a high dividend yield, the company faces significant headwinds with declining revenue and earnings, poor liquidity ratios, and negative insider sentiment. Valuation metrics appear stretched relative to fundamentals, particularly with a forward P/E of 34.02 amid negative growth. The stock trades above both the Graham Number ($17.77) and intrinsic value estimate ($7.07), suggesting overvaluation absent a turnaround.